A phase III study for evaluating the RESOLVE steroid releasing implant for the treatment of recurrent sinus obstruction post-surgery in patients with chronic sinusitis, in the office setting

Trial Profile

A phase III study for evaluating the RESOLVE steroid releasing implant for the treatment of recurrent sinus obstruction post-surgery in patients with chronic sinusitis, in the office setting

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Oct 2017

At a glance

  • Drugs Mometasone (Primary)
  • Indications Sinusitis
  • Focus Registrational; Therapeutic Use
  • Acronyms RESOLVE II
  • Sponsors Intersect ENT
  • Most Recent Events

    • 08 Oct 2017 According to an Intersect ENT media release, the company has announced data from a meta-analysis from the RESOLVE and RESOLVE II studies in September 2017.
    • 08 Oct 2017 According to an Intersect ENT media release, the results were presented at the 4th Congress of European ORL-HNS 2017.
    • 08 Oct 2017 Results published in an Intersect ENT Media Release
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top